Kyowa: Improving Lives with Health Science
KYOWA HAKKO USA, INC. is the North American sales office for KYOWA HAKKO BIO CO., LTD., and distributor for Kyowa Pharma Chemical Co. As an international health ingredients manufacturer and a world leader in the development, manufacturing and marketing of nutraceuticals, pharmaceuticals and food products, Kyowa is a pioneer in the development and application of fermentation technology and maintains an ongoing commitment to research, developing innovative new products and quality management.
Kyowa is the maker of branded ingredients including Setria® Glutathione, IMMUSE™ Lactococcus lactis strain Plasma, Cognizin® Citicoline, Pantesin® Pantethine, VELOX® Patented Performance Blend, and EYEMUSE™ Lacticaseibacillus paracasei KW3110.
Branded Ingredients for Targeted Health Benefits
![A woman with glasses studying at a table.](/storage/app/media/.resized/278/cognizin-study-27830cc4aaa81c8845c099702591504b.jpg)
![A woman in a hat looking at the sunset on top of a hill.](/storage/app/media/.resized/278/mountain-girl-27830cc4aaa81c8845c099702591504b.jpg)
![Mother and child sitting on a couch.](/storage/app/media/.resized/278/immuse-mother-child-27830cc4aaa81c8845c099702591504b.jpg)
Looking for more from Kyowa?
News
-
Unlocking Brain Health: The Power of Cognizin® Citicoline Revealed
Kyowa Hakko Bio Co., Ltd. and Kirin Holdings Company, Limited are thrilled to announce their sponsored satellite program at the American Society for Nutrition's (ASN) Annual Conference, NUTRITION 2024. This groundbreaking session will spotlight the neuroprotective effects of citicoline, revealing its potential to enhance cognitive function and combat brain aging.
-
Karen E. Todd, VP Global Marketing of Kyowa Hakko U.S.A. Named MM+M 2024 WOMEN OF DISTINCTION Honoree
Kyowa Hakko U.S.A., Inc., is delighted to announce that Karen E. Todd, RD, CSCS, EP-C, CISSN, and Vice President of Global Brand Marketing, has been named an MM+M 2024 Women of Distinction honoree.
-
Kyowa Hakko Bio Celebrates Grand Opening of Expanded Cognizin® Citicoline Manufacturing Facility in Hofu, Japan
Kyowa Hakko Bio Co., Ltd. (Kyowa Hakko Bio) & Kyowa Hakko USA, Inc (Kyowa), a subsidiary of Kirin Holdings Company, Limited (Kirin Holdings), is thrilled to announce the celebration of the grand opening of its expanded citicoline manufacturing facilities at the Kyowa Hakko Bio Yamaguchi Production Center, situated in Hofu City, Yamaguchi Prefecture, Japan.
Kyowa Memberships